Matchpoint Therapeutics
PrivateLast Round
Corporate Funding
Jul 24, 2025
Total Funding Raised
$130M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Matchpoint Therapeutics is a biotechnology company that develops precision small molecule medicines leveraging covalency to treat immune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Matchpoint Therapeutics Comparables
Compare Matchpoint Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Totus Medicines | 86% | |
| Enlaza Therapeutics | 79% | |
| Dunad Therapeutics | 77% |
Matchpoint Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 24, 2025 | ||||
| Series A | Oct 14, 2022 | ||||
| Seed | Nov 30, 2021 | ||||
| Seed | Nov 1, 2021 |
Matchpoint Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Access Industries | Seed |
| Vertex Ventures HC | Series A |
| Digitalis Ventures | Series A |
| Alexandria Venture Investments | Series A |
| Sanofi Ventures | Series A |
| Atlas Venture | Series A, Seed |
| Access Biotechnology | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 38% MoM.
- Jul 24, 2025
$60M raised in corporate funding.
Matchpoint Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Matchpoint Therapeutics's valuation, stock price, and market status.
Is Matchpoint Therapeutics a public or private company?
Matchpoint Therapeutics is a private company.
What is the current stock price of Matchpoint Therapeutics?
Matchpoint Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Matchpoint Therapeutics worth (valuation)?
Valuation information for Matchpoint Therapeutics is not publicly available.
Can I buy Matchpoint Therapeutics stock?
Matchpoint Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Matchpoint Therapeutics's last funding round?
Matchpoint Therapeutics's most recent funding round was Corporate Funding on July 24, 2025.
Who are the main investors in Matchpoint Therapeutics?
Key investors in Matchpoint Therapeutics include Access Industries, Sanofi Ventures, Atlas Venture, Access Biotechnology.
Will Matchpoint Therapeutics IPO soon?
No public IPO plans have been announced for Matchpoint Therapeutics.
How can I track Matchpoint Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Matchpoint Therapeutics's secondary market activity and sign up for updates.